Cargando…
Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report
INTRODUCTION: Angiotensin converting enzyme inhibitors (ACEI) are a common class of medications prescribed to patients for hypertension. Anti-hypertensive use is not normally considered an important factor when treating patients with crotalid envenomations; however, in combination with the venom in...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438947/ https://www.ncbi.nlm.nih.gov/pubmed/37595314 http://dx.doi.org/10.5811/cpcem.1463 |
_version_ | 1785092830802214912 |
---|---|
author | Sampson, Christopher Scott Schwarz, Evan |
author_facet | Sampson, Christopher Scott Schwarz, Evan |
author_sort | Sampson, Christopher Scott |
collection | PubMed |
description | INTRODUCTION: Angiotensin converting enzyme inhibitors (ACEI) are a common class of medications prescribed to patients for hypertension. Anti-hypertensive use is not normally considered an important factor when treating patients with crotalid envenomations; however, in combination with the venom in this patient, it may have resulted in angioedema. CASE REPORT: A 65-year-old male on ACEI presented to his community emergency department following a snake envenomation to his thumb. Six vials of Crotalidae polyvalent immune fab were administered, and he was transferred to a referral center. Approximately 18 hours after the envenomation, the patient complained of tongue swelling and difficulty speaking. There was evidence of angioedema, with the right side of the tongue significantly enlarged compared to the left. He was intubated for airway protection and remained on a ventilator for three days. CONCLUSION: Angiotensin converting enzyme inhibitors may potentiate the effects of exogenous bradykinin as some snake venom has naturally occurring bradykinin, which may further amplify its effects. Extra vigilance may be warranted for the development of angioedema in patients receiving ACEI. |
format | Online Article Text |
id | pubmed-10438947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-104389472023-08-19 Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report Sampson, Christopher Scott Schwarz, Evan Clin Pract Cases Emerg Med Case Report INTRODUCTION: Angiotensin converting enzyme inhibitors (ACEI) are a common class of medications prescribed to patients for hypertension. Anti-hypertensive use is not normally considered an important factor when treating patients with crotalid envenomations; however, in combination with the venom in this patient, it may have resulted in angioedema. CASE REPORT: A 65-year-old male on ACEI presented to his community emergency department following a snake envenomation to his thumb. Six vials of Crotalidae polyvalent immune fab were administered, and he was transferred to a referral center. Approximately 18 hours after the envenomation, the patient complained of tongue swelling and difficulty speaking. There was evidence of angioedema, with the right side of the tongue significantly enlarged compared to the left. He was intubated for airway protection and remained on a ventilator for three days. CONCLUSION: Angiotensin converting enzyme inhibitors may potentiate the effects of exogenous bradykinin as some snake venom has naturally occurring bradykinin, which may further amplify its effects. Extra vigilance may be warranted for the development of angioedema in patients receiving ACEI. University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2023-06-26 /pmc/articles/PMC10438947/ /pubmed/37595314 http://dx.doi.org/10.5811/cpcem.1463 Text en © 2023 Sampson et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) License. See: http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Case Report Sampson, Christopher Scott Schwarz, Evan Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report |
title | Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report |
title_full | Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report |
title_fullStr | Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report |
title_full_unstemmed | Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report |
title_short | Delayed-onset Angioedema Following a Snakebite in a Patient on ACE Inhibitors: A Case Report |
title_sort | delayed-onset angioedema following a snakebite in a patient on ace inhibitors: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438947/ https://www.ncbi.nlm.nih.gov/pubmed/37595314 http://dx.doi.org/10.5811/cpcem.1463 |
work_keys_str_mv | AT sampsonchristopherscott delayedonsetangioedemafollowingasnakebiteinapatientonaceinhibitorsacasereport AT schwarzevan delayedonsetangioedemafollowingasnakebiteinapatientonaceinhibitorsacasereport |